IntraLase Executive Vice President and Chief Financial Officer Adopts Rule 10b5-1 Trading Plan

Rule 10b5-1 allows corporate officers and directors to adoptwritten, pre-arranged stock trading plans when they do not havematerial, non-public information. Using these plans, insiders candiversify their investment portfolios while avoiding concerns aboutwhether they had material, non-public information when they sold theirstock.

Under her Rule 10b5-1 Plan, Thunen may sell up to 56,378 sharesover a period of approximately five months. These shares, whichrepresent less than 20 percent of Thunen's total IntraLase holdings(including stock options) have been owned by Thunen since 2002.Thunen's Rule 10b5-1 Plan has a series of laddered price triggers forthe sale of shares.

The transactions under this plan will be disclosed publiclythrough Form 144 and Form 4 filings with the Securities and ExchangeCommission.

About IntraLase Corp.

IntraLase designs, develops, and manufactures an ultra-fast laserthat is revolutionizing refractive and corneal surgery by creatingsafe and more precise corneal incisions. Delivering on the promise ofophthalmic laser technology, the IntraLase FS laser, related software,and disposable devices replace the hand-held microkeratome blade usedduring LASIK surgery. The unsurpassed accuracy of IntraLase'scomputer-controlled femtosecond laser has been shown to improve safetyprofiles and visual outcomes when used during LASIK. Additionally, theIntraLase FS laser creates precision-designed intracorneal incisionsthat when combined can be used during lamellar and penetratingkeratoplasties, and intrastromal ring implantation. IntraLase ispresently in the process of commercializing applications of itstechnology in the treatment of corneal diseases that require cornealtransplant surgery. The company's proprietary laser and disposablepatient interfaces are presently marketed throughout the United Statesand 26 other countries. IntraLase has headquarters and manufacturesits products in Irvine. For additional information, visit thecompany's Web site: www.intralase.com.